cholesterol
NICE recommends Daiichi Sankyo’s cholesterol-lowering treatments for NHS England use
March 18, 2021Daiichi Sankyo, NICE, cholesterol
NICE has recommended Daiichi Sankyo’s bempedoic acid and bempedoic acid/ezetimibe for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed …
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
NHS to pioneer Novartis injection that reduces cholesterol
January 14, 2020Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack
The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …
Half of patients have sub-optimal response to statins, research shows
April 16, 2019Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
New class of drugs offer alternative to statins
March 14, 2019Research and Development cholesterol, health, imperial college london, research, statins
A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study …
MSD gives up on cholesterol drug, despite positive results
October 12, 2017Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical
MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …
Battling misinformation on the world’s biggest killer
August 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cardiovascular disease, cholesterol, healthcare, heart disease, heart failure, medicine, pharma, pharmaceutical
Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …
‘Vaccine’ to lower cholesterol enters human trials
June 20, 2017Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes
After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …
FDA green-lights Alembic’s cholesterol drug
May 15, 2017Sales and Marketing Alembic, FDA, cholesterol
Alembic Pharmaceuticals has announced that its fenofibric acid delayed-release capsules have been approved by the FDA for reducing high cholesterol …
Pfizer surprises industry by ending development of projected blockbuster
November 1, 2016Research and Development Pfizer, cholesterol, clinical trials
Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …
Sanofi & Regeneron’s Praluent cholesterol treatment smashes Phase III target
August 30, 2016Manufacturing and Production, Research and Development Regeneron, Sanofi, apheresis, cholesterol, phase III
Sanofi and Regeneron have announced that their Praluent injection generated positive Phase III results investigating patients with an inherited form …
NICE recommends Sanofi, Amgen cholesterol drugs
May 6, 2016Medical Communications, Sales and Marketing Amgen, Draft Guidance, NHS, NICE, Repatha, Sanofi, cardiovascular disease, cholesterol, final draft guidance, high cholesterol, praluent, recommendation, treatment
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending two new drugs for the …
Allergan launches Crestor generic in the US
May 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales
Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …
Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer
April 15, 2016Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university
Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …
Amgen wins high-profile cholesterol drug patent case v Sanofi
March 17, 2016Sales and Marketing Amgen, PCSK9, Regeneron, Repatha, Sanofi, cholesterol, praluent
A Delaware district court jury has ruled in favour of Amgen in an ongoing dispute around patents for cholesterol-lowering drugs …
